Stellantis reports strong Q3 results, but warns of one-off charges ahead amid supply chain risks and muted European demand.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Microsoft's Azure experienced a major outage due to an inadvertent tenant configuration change in Azure Front Door, disrupting various services and renewing concerns about market concentration and operational resilience in the cloud industry.
Stellantis reports strong Q3 results, but warns of one-off charges ahead amid supply chain risks and muted European demand.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Microsoft's Azure experienced a major outage due to an inadvertent tenant configuration change in Azure Front Door, disrupting various services and renewing concerns about market concentration and operational resilience in the cloud industry.